| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |